R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress

Brain Res. 2010 Sep 10:1351:229-237. doi: 10.1016/j.brainres.2010.06.005. Epub 2010 Jun 12.

Abstract

The identification of rare monogenic forms of Parkinson's disease (PD) has provided tremendous insights into the molecular pathogenesis of the disorder. Mitochondrial dysfunction and oxidative stress are thought to play a prominent role in the pathogenesis of PD, but how the monogenic mutation gene causes the disease onset or progression is largely unknown. In this study we investigated the effects of wild-type and R492X mutation in the PTEN-induced putative kinase 1 (PINK1). Cell cultures show that R492X PINK1 mutation induces the generation of cellular reactive oxidative species (ROS), degrades cell membrane potential, causes cytochrome C (Cyt.C) release from mitochondrial to cytoplasm, attenuates mitochondrial complex I activity, and lastly, causes changes in mitochondrial numbers and morphology; especially when cells are treated with 1-Methyl-4-phenylpyridinium ion (MPP(+)). Our results suggest that the R492X mutation can cause mitochondrial dysfunction and oxidative stress and can associate with MPP(+) to induce mitochondrial dysfunction and oxidative stress.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium / toxicity
  • Cell Line, Tumor
  • Cell Membrane / enzymology*
  • Cell Membrane / genetics
  • Fetus
  • Humans
  • Membrane Potential, Mitochondrial / physiology
  • Mitochondria / enzymology*
  • Mitochondria / genetics*
  • Mutation / genetics*
  • Oxidative Stress / genetics*
  • Oxidative Stress / physiology
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics
  • Protein Kinases / genetics*
  • Protein Kinases / physiology
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • Protein Kinases
  • PTEN-induced putative kinase
  • 1-Methyl-4-phenylpyridinium